全文获取类型
收费全文 | 4876篇 |
免费 | 204篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 47篇 |
儿科学 | 66篇 |
妇产科学 | 27篇 |
基础医学 | 558篇 |
口腔科学 | 84篇 |
临床医学 | 278篇 |
内科学 | 1243篇 |
皮肤病学 | 62篇 |
神经病学 | 262篇 |
特种医学 | 208篇 |
外科学 | 970篇 |
综合类 | 60篇 |
预防医学 | 180篇 |
眼科学 | 126篇 |
药学 | 247篇 |
中国医学 | 33篇 |
肿瘤学 | 659篇 |
出版年
2024年 | 4篇 |
2023年 | 35篇 |
2022年 | 99篇 |
2021年 | 168篇 |
2020年 | 71篇 |
2019年 | 81篇 |
2018年 | 105篇 |
2017年 | 82篇 |
2016年 | 124篇 |
2015年 | 118篇 |
2014年 | 164篇 |
2013年 | 219篇 |
2012年 | 328篇 |
2011年 | 341篇 |
2010年 | 205篇 |
2009年 | 182篇 |
2008年 | 292篇 |
2007年 | 340篇 |
2006年 | 291篇 |
2005年 | 289篇 |
2004年 | 320篇 |
2003年 | 308篇 |
2002年 | 287篇 |
2001年 | 50篇 |
2000年 | 44篇 |
1999年 | 46篇 |
1998年 | 72篇 |
1997年 | 70篇 |
1996年 | 57篇 |
1995年 | 40篇 |
1994年 | 39篇 |
1993年 | 32篇 |
1992年 | 26篇 |
1991年 | 20篇 |
1990年 | 15篇 |
1989年 | 11篇 |
1988年 | 11篇 |
1987年 | 20篇 |
1986年 | 8篇 |
1985年 | 17篇 |
1984年 | 11篇 |
1983年 | 4篇 |
1982年 | 12篇 |
1981年 | 9篇 |
1980年 | 7篇 |
1979年 | 6篇 |
1978年 | 5篇 |
1977年 | 7篇 |
1976年 | 5篇 |
1957年 | 2篇 |
排序方式: 共有5110条查询结果,搜索用时 12 毫秒
51.
52.
Norio Tanaka Seiichi Mori Kazuma Kiyotani Yuki Ota Osamu Gotoh Shigeru Kusumoto Nobuaki Nakano Youko Suehiro Asahi Ito Ilseung Choi Eiichi Ohtsuka Michihiro Hidaka Kisato Nosaka Makoto Yoshimitsu Yoshitaka Imaizumi Shinsuke Iida Atae Utsunomiya Tetsuo Noda Hiroyoshi Nishikawa Ryuzo Ueda Takashi Ishida 《Haematologica》2022,107(10):2418
In order to identify genomic biomarkers for the outcome of mogamulizumab-containing treatment, an integrated molecular analysis of adult T-cell leukemia/lymphoma (ATL) was conducted on 64 mogamulizumab-naïve patients. Among driver genes, CCR4 and CCR7 alterations were observed in 22% and 11% of the patients, respectively, both consisting of single nucleotide variants (SNV)/insertion-deletions (indels) in the C-terminus. Patients with CCR4 alterations or without CCR7 alterations exhibited a more favorable clinical response (complete response [CR] rate 93%, 13/14; P=0.024, and CR rate 71%, 40/56; P=0.036, respectively). Additionally, TP53, CD28, and CD274 alterations were identified in 35%, 16%, and 10% of the patients, respectively. TP53 alterations included SNV/indels or copy number variations (CNV) such as homozygous deletion; CD28 alterations included SNV, CNV such as amplification, or fusion; CD274 alterations included CNV such as amplification, or structural variants. Univariate analysis revealed that TP53, CD28 or CD274 alterations were associated with worse overall survival (OS) (hazard ratio [HR]: 2.330, 95% confidence interval [CI]: 1.183-4.589; HR: 3.191, 95% CI: 1.287-7.911; HR: 3.301, 95% CI: 1.130-9.641, respectively) but that CCR4 alterations were associated with better OS (HR: 0.286, 95% CI: 0.087-0.933). Multivariate analysis indicated that in addition to performance status, TP53, CCR4 or CD274 alterations (HR: 2.467, 95% CI: 1.197-5.085; HR: 0.155, 95% CI: 0.031-0.778; HR: 14.393, 95% CI: 2.437-85.005, respectively) were independently and significantly associated with OS. The present study contributes to the establishment of precision medicine using mogamulizumab in ATL patients. 相似文献
53.
Yusaku Miyata Naoya Murakami Yoshitaka Honma Taisuke Mori Seiichi Yoshimoto Tairo Kashihara Mihiro Takemori Yuko Nakayama Jun Itami Etsuyo Ogo Hiroshi Igaki 《Journal of radiation research》2022,63(6):879
Sinonasal undifferentiated carcinoma (SNUC) is a highly aggressive and uncommon neoplasm that arises from the mucosa of the nasal cavity or paranasal sinuses. The multidisciplinary approach that includes surgery, radiation therapy (RT), and chemotherapy has been proven to improve survival rates. However, there is no established evidence for the efficacy of further (boost) irradiation following definitive RT in SNUC patients with residual primary tumor. We describe a successful case of a patient with SNUC who had an uncontrolled primary tumor following induction chemotherapy and radical concurrent chemoradiotherapy (CCRT) and underwent a high-dose-rate interstitial brachytherapy (HDR-ISBT) boost. A 75-year-old Japanese woman with unresectable locally advanced SNUC (LA-SNUC) received induction chemotherapy followed by radical CCRT. However, because the residual primary tumor was evident after planned external beam RT, she underwent an HDR-ISBT boost, and the tumor decreased significantly. A complete response (the Response Evaluation Criteria in Solid Tumors, ver. 1.1) was achieved 2 months after brachytherapy, and the patient has been disease-free for 2 years following treatment initiation. In conclusion, an HDR-ISBT boost can be a safe and effective treatment option in patients with residual and inoperable LA-SNUC in the maxillary sinus after initial RT. 相似文献
54.
Ryusei Uchio Chinatsu Okuda-Hanafusa Ryosuke Saji Kengo Kawasaki Koutarou Muroyama Shinji Murosaki Yoshihiro Yamamoto Yoshitaka Hirose 《Nutrients》2022,14(18)
The dietary spice Curcuma longa L. (C. longa), also known as turmeric, has various biological effects. A hot water extract of C. longa was shown to have anti-inflammatory activities in preclinical and clinical studies. Chronic low-grade inflammation is associated with the disruption of glucose homeostasis, but the effect of C. longa extract on glucose metabolism in humans is poorly understood. Therefore, we investigated the effect of C. longa extracts on serum glucose levels in the presence of low-grade inflammation. We reanalyzed our published data from two randomized, double-blind, placebo-controlled trials in overweight participants aged 50 to 69 years and performed a stratified analysis using the inflammatory marker high-sensitivity C-reactive protein (hsCRP). In both studies, participants took a test food with a hot water extract of C. longa (C. longa extract group, n = 45 per study) or without C. longa extract (placebo group, n = 45 per study) daily for 12 weeks, and we measured the levels of serum hsCRP and fasting serum glucose. The mean baseline hsCRP value was used to stratify participants into two subgroups: a low-hsCRP subgroup (baseline mean hsCRP < 0.098 mg/dL) and a high-hsCRP subgroup (baseline mean hsCRP ≥ 0.098 mg/dL). In the low-hsCRP subgroup, we found no significant difference in fasting serum glucose levels between the two groups in either study, but in the high-hsCRP subgroup, the C. longa extract group had significantly lower levels of serum hsCRP (p < 0.05) and fasting serum glucose (p < 0.05) than the placebo group in both studies. In conclusion, a hot water extract of C. longa may help to improve systemic glucose metabolism in people with chronic low-grade inflammation. 相似文献
55.
Maya Takegami Yoshitaka Hashimoto Masahide Hamaguchi Ayumi Kaji Ryosuke Sakai Takuro Okamura Noriyuki Kitagawa Takafumi Osaka Hiroshi Okada Naoko Nakanishi Saori Majima Takafumi Senmaru Emi Ushigome Mai Asano Masahiro Yamazaki Michiaki Fukui 《Journal of Clinical Biochemistry and Nutrition》2022,71(2):136
This cross-sectional study investigated the association of metabolic syndrome (MetS) with sarcopenia defined by absolute low muscle mass (aLMM) and absolute low muscle strength (aLMS), or sarcopenia defined by relative low muscle mass (rLMM) and relative low muscle strength (rLMS). The cut-off values for men and women were as follows: aLMM, appendicular muscle mass in kg/height2 was <7.0 kg/m2 and <5.7 kg/m2; rLMM, appendicular muscle mass/body weight ×100 was <28.64% and <24.12%; aLMS, handgrip strength was <28 kg and <18 kg; and rLMS, handgrip strength/body weight ×100 was 51.26% and 35.38%. Among 207 men and 164 women, 41.5% men and 57.3% women had MetS, 14.0% men and 6.1% women had sarcopenia as defined by aLMM and aLMS, and 14.0% men and 22.0% women had sarcopenia defined by rLMM and rLMS. Compared with non-sarcopenia, adjusted OR of sarcopenia defined by aLMM and aLMS for the prevalence of MetS was 0.79 (95% CI 0.38–1.67), whereas that of sarcopenia defined by rLMM and rLMS for the prevalence of MetS was 20.6 (95% CI 7.81–54.3). Sarcopenia defined by rLMM and rLMS was associated with the risk of prevalence of MetS, whereas sarcopenia defined by aLMM and aLMS was not. 相似文献
56.
57.
Ayasa Nitta Saeko Imai Shizuo Kajiayama Mikuko Matsuda Takashi Miyawaki Shinya Matsumoto Shintaro Kajiyama Yoshitaka Hashimoto Neiko Ozasa Michiaki Fukui 《Nutrients》2022,14(14)
The aim of this retrospective cohort study was to evaluate the effect of 5-year follow-up of dietitian-led medical nutrition therapy (eating vegetables before carbohydrates) on glycemic control in outpatients with type 2 diabetes (T2DM) at a primary care clinic. A total of 138 patients with dietitian-led medical nutrition therapy (intervention group) and 104 patients without dietitian-led nutrition therapy (control group) were compared for glycemic control, serum lipid, blood pressure, and diabetic complications for 5 years. Each patient in the intervention group received dietary education focused on food order (eating vegetables before carbohydrates) by dietitians. A significant improvement in HbA1c after 5 years in the intervention group [8.5 ± 1.7% (69 mmol/mol) to 7.6 ± 1.1% (59 mmol/mol), p < 0.001] was observed, whereas no change was observed in the control group [7.9 ± 1.2% (62 mmol/mol) to 8.0 ± 1.2% (63 mmol/mol)]. Dietary intake of protein, fat, carbohydrates, cholesterol, and salt in the intervention group demonstrated significant reduction, while the intake of dietary fiber significantly increased after the dietary education. Simple dietary education of ‘eating vegetables before carbohydrates’ presented by dietitians achieved good glycemic control after a 5-year period in outpatients with T2DM at primary care clinic. 相似文献
58.
Masami Goto Osamu Abe Akifumi Hagiwara Shohei Fujita Koji Kamagata Masaaki Hori Shigeki Aoki Takahiro Osada Seiki Konishi Yoshitaka Masutani Hajime Sakamoto Yasuaki Sakano Shinsuke Kyogoku Hiroyuki Daida 《Magnetic resonance in medical sciences》2022,21(1):41
Surface-based morphometry (SBM) is extremely useful for estimating the indices of cortical morphology, such as volume, thickness, area, and gyrification, whereas voxel-based morphometry (VBM) is a typical method of gray matter (GM) volumetry that includes cortex measurement. In cases where SBM is used to estimate cortical morphology, it remains controversial as to whether VBM should be used in addition to estimate GM volume. Therefore, this review has two main goals. First, we summarize the differences between the two methods regarding preprocessing, statistical analysis, and reliability. Second, we review studies that estimate cortical morphological changes using VBM and/or SBM and discuss whether using VBM in conjunction with SBM produces additional values. We found cases in which detection of morphological change in either VBM or SBM was superior, and others that showed equivalent performance between the two methods. Therefore, we concluded that using VBM and SBM together can help researchers and clinicians obtain a better understanding of normal neurobiological processes of the brain. Moreover, the use of both methods may improve the accuracy of the detection of morphological changes when comparing the data of patients and controls.In addition, we introduce two other recent methods as future directions for estimating cortical morphological changes: a multi-modal parcellation method using structural and functional images, and a synthetic segmentation method using multi-contrast images (such as T1- and proton density-weighted images). 相似文献
59.
本研究在水热条件下利用羧甲基壳聚糖分别还原硝酸银和硫酸铜,得到稳定的羧甲基壳聚糖复合纳米银和纳米氧化铜,并测试其抑菌能力.表征测试显示,所制的纳米银为20~30 nm的球状结构,纳米氧化铜为80~100 nm的花瓣状结构,二者都均匀稳定地分布于羧甲基壳聚糖中.抑菌试验显示,不同浓度的羧甲基壳聚糖复合纳米银(A组2 mg... 相似文献
60.
该文考察中药甘遂的量-毒-效关系,探讨甘遂的毒效变化特点,为临床安全合理用药提供科学依据。以恶性胸水模型为研究对象,在较大剂量范围内(甘遂0.045~1.620 g·kg~(-1)·d~(-1))考察甘遂对实验动物生化指标、胸水量等的影响,并通过因子分析方法综合评价甘遂的量-毒-效关系。结果显示,模型组大鼠具有较多的胸水量,且与空白组比较,ALT,AST,LDH,HBDH,IFN-γ,IL-2,TNF-α显著升高(P0.05),TP,ALB降低(P0.05)。给药后,与模型组比较,各组可不同程度的减少胸水量,降低IFN-γ,IL-2,TNF-α,升高TP,ALB,体现出一定的治疗作用,同时引起ALT,AST,LDH,HBDH升高,体现出一定的肝、心脏毒性。通过因子分析从9个指标中抽提出2个公因子,共解释了89.1%的信息。结果表明,甘遂在《中国药典》剂量范围内单独给药没有见到明显毒性,在药典高限3倍剂量下可产生肝脏、心脏毒性,随着剂量增加,毒性增强;同时甘遂具有"峻下逐水"功效,可减少恶性胸水模型大鼠的胸水量及改善相关生理指标,且具有剂量依赖性。综合分析其毒效特点,甘遂药典高限剂量为其相对最佳治疗剂量。 相似文献